Background After having one of the most restrictive abortion laws worldwide, Ireland legalised abortion in January 2019. We examine how legalisation impacted on demand for online telemedicine outside the jurisdiction.
Methods We analysed anonymised data from 534 people from Ireland seeking online telemedicine abortion prior to legalisation (January–March and October–December 2018) and in the first 3 months following legalisation (January–March 2019). Numbers, characteristics and reasons for seeking the service before and after legalisation were compared. Content analysis of emails from people seeking the service following legalisation explored reasons for seeking care.
Results Half as many people contacted Women on Web in the 3 months immediately after legalisation as compared with contacts 12 months prior (103 vs 221). Of these, the proportion receiving the service reduced, from 72% prior to legalisation to 26% after legalisation (p≤0.001). After legalisation, access related reasons for seeking online telemedicine featured less while reasons relating to privacy, stigma and avoiding protestors featured more.
Conclusions People continued to seek abortion through online telemedicine after legalisation, though the number of contacts reduced by half and the proportion receiving the service decreased considerably. To address access issues, policy measures should promote normalisation of abortion, legislate for safe zones around providers, and consider access in situations of coercive control or abuse including the role of telemedicine in the local model of care. Abortion provided through online telemedicine continues to be an important part of providing safe, accessible abortion even after legalisation.
- reproductive health
- reproductive rights
- health policy
Data availability statement
Data may be obtained from a third party and are not publicly available. Women on Web (www.womenonweb.org) hold these data and may make fully de-identified data availble to researchers on application.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Correction notice This article has been corrected since it first published. The provenance and peer review statement has been included.
Contributors RG and ARAA planned and designed the study. RG generated the study data. SB and MK carried out the data analysis and wrote up an extended version of the findings from which SB, MK, RG and ARAA developed an extended discussion. CC devised the format for this article using extended analysis and discussion by SB, MK, RG and ARAA, distilled the discussion and developed the conclusions. All authors contributed to revisions for the final draft. CC submitted the article and is the corresponding author.
Funding CC’s contribution to this study was supported by funding from the HSE Award Number 16123 Unplanned Pregnancy and Abortion Care (UnPAC) study for which CC is the Principal Investigator.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Not commissioned; externally peer reviewed.